Could a parasite drug beat warts? new trial tests ivermectin
NCT ID NCT07396714
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial will test whether a cream containing ivermectin (a drug used for parasites) can treat common skin warts. It will compare ivermectin alone, ivermectin combined with microneedling (tiny needles to help the cream absorb), and a standard salicylic acid treatment. The study plans to enroll 88 people aged 11 to 80 with non-genital warts and will check results every two weeks for up to 12 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
topical ivermectin 1%
What this could lead to
If it works, this could offer a new topical treatment option for common skin warts.
What could go wrong
This is a very early, small trial (88 people) with no results yet. The treatment may not work better than existing options, and side effects are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WARTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••